Obesity and colorectal cancer: Epidemiology, mechanisms and candidate genes

Journal of Nutritional Biochemistry

Volumn 17, Issue 3, 2006, Pages 145-156

  Gunter, Marc J ^a   Leitzmann, Michael F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Body size; Colorectal cancer; Genetics; Insulin resistance; Obesity

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN;

ADIPOCYTE; BODY SIZE; CALORIC INTAKE; CELL DIFFERENTIATION; CELL METABOLISM; CHRONIC INFLAMMATION; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENERGY EXPENDITURE; FATTY ACID BLOOD LEVEL; GENE FUNCTION; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; GENOMICS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MACRONUTRIENT; MITOGENESIS; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PHYSICAL ACTIVITY; REVIEW;

ADIPOCYTES; ANIMALS; BODY SIZE; CELL DIFFERENTIATION; CHRONIC DISEASE; COLONIC NEOPLASMS; DIET; ENERGY METABOLISM; EXERCISE; GROWTH HORMONE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; OBESITY; SIGNAL TRANSDUCTION;

EID: 32644485492     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2005.06.011     Document Type: Review

References (157)

1. International Obesity Taskforce http://www.iotf.org [accessed 2005]
2. K.M. Flegal, M.D. Carroll, C.L. Ogden, and C.L. Johnson Prevalence and trends in obesity among US adults, 1999-2000 JAMA 288 2002 1723 1727
3. J.C. Seidell Obesity, insulin resistance and diabetes - a worldwide epidemic Br J Nutr 83 Suppl 1 2000 S5 S8
4. IARC Weight control and physical activity IARC handbooks of cancer prevention vol. 6 2002 IARC Press Lyon, France
5. D.M. Parkin, S.L. Whelan, J. Ferlay, L. Teppo, and D.B. Thomas Cancer incidence in five continents vol. 155 2002 IARC Press Lyon, France
6. G. Steinbach, S.P. Kumar, B.S. Reddy, M. Lipkin, and P.R. Holt Effects of caloric restriction and dietary fat on epithelial cell proliferation in rat colon Cancer Res 53 1993 2745 2749
7. F. Premoselli, E. Sesca, V. Binasco, G. Caderni, and L. Tessitore Fasting/re-feeding before initiation enhances the growth of aberrant crypt foci induced by azoxymethane in rat colon and rectum Int J Cancer 77 1998 286 294
8. C. Bouchard Genetics of obesity: overview and research directions Genetics Obesity 1994 223 233
9. S. Graham, J. Marshall, B. Haughey, A. Mittelman, M. Swanson, and M. Zielezny Dietary epidemiology of cancer of the colon in western New York Am J Epidemiol 128 1988 490 503
10. G.A. Kune, S. Kune, and L.F. Watson Body weight and physical activity as predictors of colorectal cancer risk Nutr Cancer 13 1990 9 17
11. M. Gerhardsson de Verdier, U. Hagman, G. Steineck, A. Rieger, and S.E. Norell Diet, body mass and colorectal cancer: a case-referent study in Stockholm Int J Cancer 46 1990 832 838
12. L. Le Marchand, L.R. Wilkens, L.N. Kolonel, J.H. Hankin, and L.C. Lyu Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer Cancer Res 57 1997 4787 4794
13. B.J. Caan, A.O. Coates, M.L. Slattery, J.D. Potter, C.P. Quesenberry Jr, and S.M. Edwards Body size and the risk of colon cancer in a large case-control study Int J Obes Relat Metab Disord 22 1998 178 184
14. A. Russo, S. Franceschi, C. La Vecchia, L. Dal Maso, M. Montella, and E. Conti Body size and colorectal-cancer risk Int J Cancer 78 1998 161 165
15. A.T. Dietz, P.A. Newcomb, P.M. Marcus, and B.E. Storer The association of body size and large bowel cancer risk in Wisconsin (United States) women Cancer Causes Control 6 1995 30 36
16. M.C. Boutron-Ruault, P. Senesse, S. Meance, C. Belghiti, and J. Faivre Energy intake, body mass index, physical activity, and the colorectal adenoma-carcinoma sequence Nutr Cancer 39 2001 50 57
17. I.M. Lee, and R.S. Paffenbarger Jr Quetelet's index and risk of colon cancer in college alumni J Natl Cancer Inst 84 1992 1326 1331
18. R.M. Bostick, J.D. Potter, L.H. Kushi, T.A. Sellers, K.A. Steinmetz, and D.R. McKenzie Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States) Cancer Causes Control 5 1994 38 52
19. P.H. Chyou, A.M. Nomura, and G.N. Stemmermann A prospective study of weight, body mass index and other anthropometric measurements in relation to site-specific cancers Int J Cancer 57 1994 313 317
20. E. Giovannucci, A. Ascherio, E.B. Rimm, G.A. Colditz, M.J. Stampfer, and W.C. Willett Physical activity, obesity, and risk for colon cancer and adenoma in men Ann Intern Med 122 1995 327 334
21. M.E. Martinez, E. Giovannucci, D. Spiegelman, D.J. Hunter, W.C. Willett, and G.A. Colditz Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group J Natl Cancer Inst 89 1997 948 955
22. E.S. Ford Body mass index and colon cancer in a national sample of adult US men and women Am J Epidemiol 150 1999 390 398
23. T.K. Murphy, E.E. Calle, C. Rodriguez, H.S. Kahn, and M.J. Thun Body mass index and colon cancer mortality in a large prospective study Am J Epidemiol 152 2000 847 854
24. J. Lin, S.M. Zhang, N.R. Cook, K.M. Rexrode, I.M. Lee, and J.E. Buring Body mass index and risk of colorectal cancer in women (United States) Cancer Causes Control 15 2004 581 589
25. K. Tamakoshi, K. Wakai, M. Kojima, Y. Watanabe, N. Hayakawa, and H. Toyoshima A prospective study of body size and colon cancer mortality in Japan: the JACC Study Int J Obes Relat Metab Disord 28 2004 551 558
26. L.L. Moore, M.L. Bradlee, M.R. Singer, G.L. Splansky, M.H. Proctor, and R.C. Ellison BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults Int J Obes Relat Metab Disord 28 2004 559 567
27. A.I. Neugut, W.C. Lee, G.C. Garbowski, J.D. Waye, K.A. Forde, and M.R. Treat Obesity and colorectal adenomatous polyps J Natl Cancer Inst 83 1991 359 361
28. K. Shinchi, S. Kono, S. Honjo, I. Todoroki, Y. Sakurai, and K. Imanishi Obesity and adenomatous polyps of the sigmoid colon Jpn J Cancer Res 85 1994 479 484
29. A.L. Davidow, A.I. Neugut, J.S. Jacobson, H. Ahsan, G.C. Garbowski, and K.A. Forde Recurrent adenomatous polyps and body mass index Cancer Epidemiol Biomarkers Prev 5 1996 313 315
30. E. Giovannucci, G.A. Colditz, M.J. Stampfer, and W.C. Willett Physical activity, obesity, and risk of colorectal adenoma in women (United States) Cancer Causes Control 7 1996 253 263
31. C.L. Bird, H.D. Frankl, E.R. Lee, and R.W. Haile Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum Am J Epidemiol 147 1998 670 680
32. S. Kono, K. Handa, H. Hayabuchi, C. Kiyohara, H. Inoue, and T. Marugame Obesity, weight gain and risk of colon adenomas in Japanese men Jpn J Cancer Res 90 1999 805 811
33. R.J. MacInnis, D.R. English, J.L. Hopper, A.M. Haydon, D.M. Gertig, and G.G. Giles Body size and composition and colon cancer risk in men Cancer Epidemiol Biomarkers Prev 13 2004 553 559
34. W. Willett, and M.J. Stampfer Total energy intake: implications for epidemiologic analyses Am J Epidemiol 124 1986 17 27
35. M.L. Slattery, B.J. Caan, J.D. Potter, T.D. Berry, A. Coates, and D. Duncan Dietary energy sources and colon cancer risk Am J Epidemiol 145 1997 199 210
36. S. Franceschi, L. Dal Maso, L. Augustin, E. Negri, M. Parpinel, and P. Boyle Dietary glycemic load and colorectal cancer risk Ann Oncol 12 2001 173 178
37. S. Higginbotham, Z.F. Zhang, I.M. Lee, N.R. Cook, E. Giovannucci, and J.E. Buring Dietary glycemic load and risk of colorectal cancer in the Women's Health Study J Natl Cancer Inst 96 2004 229 233
38. D.S. Michaud, C.S. Fuchs, S. Liu, W.C. Willett, G.A. Colditz, and E. Giovannucci Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women Cancer Epidemiol Biomarkers Prev 14 2005 138 147
39. L. Kushi, and E. Giovannucci Dietary fat and cancer Am J Med 113 Suppl 9B 2002 63S 70S
40. C.M. Friedenreich, and M.R. Orenstein Physical activity and cancer prevention: etiologic evidence and biological mechanisms J Nutr 132 2002 3456S 3464S
41. K.T. Khaw, N. Wareham, S. Bingham, R. Luben, A. Welch, and N. Day Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer - Norfolk study Cancer Epidemiol Biomarkers Prev 13 2004 915 919
42. D. Yam, A. Fink, A. Mashiah, and E. Ben-Hur Hyperinsulinemia in colon, stomach and breast cancer patients Cancer Lett 104 1996 129 132
43. T.I. Nilsen, and L.J. Vatten Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis Br J Cancer 84 2001 417 422
44. E.A. Platz, S.E. Hankinson, N. Rifai, G.A. Colditz, F.E. Speizer, and E. Giovannucci Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States) Cancer Causes Control 10 1999 379 386
45. R. Kaaks, P. Toniolo, A. Akhmedkhanov, A. Lukanova, C. Biessy, and H. Dechaud Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women J Natl Cancer Inst 92 2000 1592 1600
46. S.H. Jee, H. Ohrr, J.W. Sull, J.E. Yun, M. Ji, and J.M. Samet Fasting serum glucose level and cancer risk in Korean men and women JAMA 293 2005 194 202
47. S.H. Saydah, E.A. Platz, N. Rifai, M.N. Pollak, F.L. Brancati, and K.J. Helzlsouer Association of markers of insulin and glucose control with subsequent colorectal cancer risk Cancer Epidemiol Biomarkers Prev 12 2003 412 418
48. J. Ma, M.N. Pollak, E. Giovannucci, J.M. Chan, Y. Tao, and C.H. Hennekens Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3 J Natl Cancer Inst 91 1999 620 625
49. K. Yamada, S. Araki, M. Tamura, I. Sakai, Y. Takahashi, and H. Kashihara Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ Int J Epidemiol 27 1998 794 798
50. R.E. Schoen, C.M. Tangen, L.H. Kuller, G.L. Burke, M. Cushman, and R.P. Tracy Increased blood glucose and insulin, body size, and incident colorectal cancer J Natl Cancer Inst 91 1999 1147 1154
51. G. McKeown-Eyssen Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3 1994 687 695
52. Y.I. Kim Diet, lifestyle, and colorectal cancer: is hyperinsulinemia the missing link? Nutr Rev 56 1998 275 279
53. E. Giovannucci Insulin, insulin-like growth factors and colon cancer: a review of the evidence J Nutr 131 2001 3109S 3120S
54. M. Koenuma, T. Yamori, and T. Tsuruo Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26 Jpn J Cancer Res 80 1989 51 58
55. X. Wu, Z. Fan, H. Masui, N. Rosen, and J. Mendelsohn Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin J Clin Invest 95 1995 1897 1905
56. J. Bjork, J. Nilsson, R. Hultcrantz, and C. Johansson Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29 Scand J Gastroenterol 28 1993 879 884
57. T.T. Tran, A. Medline, and W.R. Bruce Insulin promotion of colon tumors in rats Cancer Epidemiol Biomarkers Prev 5 1996 1013 1015
58. D.E. Corpet, C. Jacquinet, G. Peiffer, and S. Tache Insulin injections promote the growth of aberrant crypt foci in the colon of rats Nutr Cancer 27 1997 316 320
59. A.R. Saltiel, and C.R. Kahn Insulin signalling and the regulation of glucose and lipid metabolism Nature 414 2001 799 806
60. M. Prentki New insights into pancreatic beta-cell metabolic signaling in insulin secretion Eur J Endocrinol 134 1996 272 286
61. I.P. Torra, G. Chinetti, C. Duval, J.C. Fruchart, and B. Staels Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice Curr Opin Lipidol 12 2001 245 254
62. P. Sarraf, E. Mueller, W.M. Smith, H.M. Wright, J.B. Kum, and L.A. Aaltonen Loss-of-function mutations in PPAR gamma associated with human colon cancer Mol Cell 3 1999 799 804
63. A.S. Doney, B. Fischer, J.E. Cecil, K. Boylan, F.E. McGuigan, and S.H. Ralston Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes Diabetologia 47 2004 555 558
64. H.H. Draper, and W.J. Bettger Role of nutrients in the cause and prevention of oxygen radical pathology Adv Exp Med Biol 366 1994 269 289
65. G. Paolisso, and D. Giugliano Oxidative stress and insulin action: is there a relationship? Diabetologia 39 1996 357 363
66. P. Dandona, K. Thusu, S. Cook, B. Snyder, J. Makowski, and D. Armstrong Oxidative damage to DNA in diabetes mellitus Lancet 347 1996 444 445
67. M.M. Rechler Growth inhibition by insulin-like growth factor (IGF) binding protein-3 - what's IGF got to do with it? Endocrinology 138 1997 2645 2647
68. P.J. Jenkins, P.D. Fairclough, T. Richards, D.G. Lowe, J. Monson, and A. Grossman Acromegaly, colonic polyps and carcinoma Clin Endocrinol (Oxf) 47 1997 17 22
69. R. Kaaks, A. Lukanova, and B. Sommersberg Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review Prostate Cancer Prostatic Dis 3 2000 157 172
70. K. Esposito, F. Nappo, R. Marfella, G. Giugliano, F. Giugliano, and M. Ciotola Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress Circulation 106 2002 2067 2072
71. P. Mohanty, W. Hamouda, R. Garg, A. Aljada, H. Ghanim, and P. Dandona Glucose challenge stimulates reactive oxygen species (ROS) generation by leukocytes J Clin Endocrinol Metab 85 2000 2970 2973
72. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91
73. P.A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance Am J Physiol Endocrinol Metab 280 2001 E745 E751
74. J.A. Eaden, K.R. Abrams, and J.F. Mayberry The risk of colorectal cancer in ulcerative colitis: a meta-analysis Gut 48 2001 526 535
75. IARC Non-steroidal anti-inflammatory drugs IARC handbooks of cancer prevention vol. 1 1997 IARC Press Lyon, France
76. T.P. Erlinger, E.A. Platz, N. Rifai, and K.J. Helzlsouer C-reactive protein and the risk of incident colorectal cancer JAMA 291 2004 585 590
77. Gunter MJ, Stolzenberg-Solomon R, Cross AJ, Leitzmann MF, Wood R, Taylor P, et al. Serum C-reactive protein levels and incident colorectal cancer risk in a cohort of Finnish male smokers. [Manuscript in preparation] 2005.
78. S.M. Zhang, J.E. Buring, I.M. Lee, N.R. Cook, and P.M. Ridker C-reactive protein levels are not associated with increased risk for colorectal cancer in women Ann Intern Med 142 2005 425 432
79. M. Jaiswal, N.F. LaRusso, L.J. Burgart, and G.J. Gores Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism Cancer Res 60 2000 184 190
80. J.R. Jackson, M.P. Seed, C.H. Kircher, D.A. Willoughby, and J.D. Winkler The codependence of angiogenesis and chronic inflammation FASEB J 11 1997 457 465
81. R.F. Grimble Inflammatory status and insulin resistance Curr Opin Clin Nutr Metab Care 5 2002 551 559
82. E.S. Ford, W.H. Giles, A.H. Mokdad, and G.L. Myers Distribution and correlates of C-reactive protein concentrations among adult US women Clin Chem 50 2004 574 581
83. A.D. Pradhan, J.E. Manson, N. Rifai, J.E. Buring, and P.M. Ridker C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 2001 327 334
84. K.T. Uysal, S.M. Wiesbrock, M.W. Marino, and G.S. Hotamisligil Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function Nature 389 1997 610 614
85. G.S. Hotamisligil, D.L. Murray, L.N. Choy, and B.M. Spiegelman Tumor necrosis factor alpha inhibits signaling from the insulin receptor Proc Natl Acad Sci U S A 91 1994 4854 4858
86. G.S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, M.F. White, and B.M. Spiegelman IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance Science 271 1996 665 668
87. B. Emanuelli, P. Peraldi, C. Filloux, C. Chavey, K. Freidinger, and D.J. Hilton Obberghen, SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice J Biol Chem 276 2001 47944 47949
88. K. Nonogaki, G.M. Fuller, N.L. Fuentes, A.H. Moser, I. Staprans, and C. Grunfeld Interleukin-6 stimulates hepatic triglyceride secretion in rats Endocrinology 136 1995 2143 2149
89. G.I. Shulman Cellular mechanisms of insulin resistance J Clin Invest 106 2000 171 176
90. S.A. Coady, C.E. Jaquish, R.R. Fabsitz, M.G. Larson, L.A. Cupples, and R.H. Myers Genetic variability of adult body mass index: a longitudinal assessment in Framingham families Obes Res 10 2002 675 681
91. K.K. Ong, D.I. Phillips, C. Fall, J. Poulton, S.T. Bennett, and J. Golding The insulin gene VNTR, type 2 diabetes and birth weight Nat Genet 21 1999 262 263
92. C. Le Stunff, D. Fallin, N.J. Schork, and P. Bougneres The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity Nat Genet 26 2000 444 446
93. L.M. Hart, R.P. Stolk, R.J. Heine, D.E. Grobbee, F.E. van der Does, and J.A. Maassen Association of the insulin-receptor variant Met-985 with hyperglycemia and non-insulin-dependent diabetes mellitus in the Netherlands: a population-based study Am J Hum Genet 59 1996 1119 1125
94. K. Almind, G. Inoue, O. Pedersen, and C.R. Kahn A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies J Clin Invest 97 1996 2569 2575
95. R. Yoshimura, E. Araki, S. Ura, M. Todaka, K. Tsuruzoe, and N. Furukawa Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites result in impaired function at different steps of IRS-1 signaling Diabetes 46 1997 929 936
96. G.A. Hitman, K. Hawrami, M.I. McCarthy, M. Viswanathan, C. Snehalatha, and A. Ramachandran Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease Diabetologia 38 1995 481 486
97. J.O. Clausen, T. Hansen, C. Bjorbaek, S.M. Echwald, S.A. Urhammer, and S. Rasmussen Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1 Lancet 346 1995 397 402
98. M.L. Slattery, W. Samowitz, K. Curtin, K.N. Ma, M. Hoffman, and B. Caan Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer Cancer Epidemiol Biomarkers Prev 13 2004 1206 1214
99. D.J. Withers, J.S. Gutierrez, H. Towery, D.J. Burks, J.M. Ren, and S. Previs Disruption of IRS-2 causes type 2 diabetes in mice Nature 391 1998 900 904
100. D. Bernal, K. Almind, L. Yenush, M. Ayoub, Y. Zhang, and L. Rosshani Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians Diabetes 47 1998 976 979
101. K. Kalidas, J. Wasson, B. Glaser, J.M. Meyer, L.J. Duprat, and M.F. White Mapping of the human insulin receptor substrate-2 gene, identification of a linked polymorphic marker and linkage analysis in families with type II diabetes: no evidence for a major susceptibility role Diabetologia 41 1998 1389 1391
102. A. Bektas, J.H. Warram, M.F. White, A.S. Krolewski, and A. Doria Exclusion of insulin receptor substrate 2 (IRS-2) as a major locus for early-onset autosomal dominant type 2 diabetes Diabetes 48 1999 640 642
103. C. Lautier, S.A. El Mkadem, E. Renard, J.F. Brun, J.C. Gris, and J. Bringer Complex haplotypes of IRS2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation Hum Genet 113 2003 34 43
104. M. Bjornholm, Y. Kawano, M. Lehtihet, and J.R. Zierath Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation Diabetes 46 1997 524 527
105. M. Otsu, I. Hiles, I. Gout, M.J. Fry, F. Ruiz-Larrea, and G. Panayotou Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase Cell 65 1991 91 104
106. D.A. Antonetti, P. Algenstaedt, and C.R. Kahn Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain Mol Cell Biol 16 1996 2195 2203
107. T. Hansen, C.B. Andersen, S.M. Echwald, S.A. Urhammer, J.O. Clausen, and H. Vestergaard Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index Diabetes 46 1997 494 501
108. C.J. Rosen, E.S. Kurland, D. Vereault, R.A. Adler, P.J. Rackoff, and W.Y. Craig Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density J Clin Endocrinol Metab 83 1998 2286 2290
109. G. Sun, J. Gagnon, Y.C. Chagnon, L. Perusse, J.P. Despres, and A.S. Leon Association and linkage between an insulin-like growth factor-1 gene polymorphism and fat free mass in the HERITAGE Family Study Int J Obes Relat Metab Disord 23 1999 929 935
110. M.L. Slattery, M. Murtaugh, B. Caan, K.N. Ma, S. Neuhausen, and W. Samowitz Energy balance, insulin-related genes and risk of colon and rectal cancer Int J Cancer 115 2005 148 154
111. C. Nezer, L. Moreau, B. Brouwers, W. Coppieters, J. Detilleux, and R. Hanset An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs Nat Genet 21 1999 155 156
112. T. Rice, Y.C. Chagnon, L. Perusse, I.B. Borecki, O. Ukkola, and T. Rankinen A genomewide linkage scan for abdominal subcutaneous and visceral fat in black and white families: the HERITAGE Family Study Diabetes 51 2002 848 855
113. S.D. O'Dell, G.J. Miller, J.A. Cooper, P.C. Hindmarsh, P.J. Pringle, and H. Ford Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males Int J Obes Relat Metab Disord 21 1997 822 825
114. T.R. Gaunt, J.A. Cooper, G.J. Miller, I.N. Day, and S.D. O'Dell Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males Hum Mol Genet 10 2001 1491 1501
115. S. Rodriguez, T.R. Gaunt, S.D. O'Dell, X.H. Chen, D. Gu, and E. Hawe Haplotypic analyses of the IGF2-INS-TH gene cluster in relation to cardiovascular risk traits Hum Mol Genet 13 2004 715 725
116. L. Le Marchand, T. Donlon, A. Seifried, R. Kaaks, S. Rinaldi, and L.R. Wilkens Association of a common polymorphism in the human GH1 gene with colorectal neoplasia J Natl Cancer Inst 94 2002 454 460
117. J.M. Fernandez-Real, C. Gutierrez, W. Ricart, R. Casamitjana, M. Fernandez-Castaner, and J. Vendrell The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels Diabetes 46 1997 1468 1472
118. S.M. Herrmann, S. Ricard, V. Nicaud, C. Mallet, D. Arveiler, and A. Evans Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity Eur J Clin Invest 28 1998 59 66
119. J. Hoffstedt, P. Eriksson, L. Hellstrom, S. Rossner, M. Ryden, and P. Arner Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men Diabetologia 43 2000 117 120
120. J.W. Kolaczynski, J.P. Ohannesian, R.V. Considine, C.C. Marco, and J.F. Caro Response of leptin to short-term and prolonged overfeeding in humans J Clin Endocrinol Metab 81 1996 4162 4165
121. J. Dallongeville, B. Hecquet, P. Lebel, J.L. Edme, C. Le Fur, and J.C. Fruchart Short term response of circulating leptin to feeding and fasting in man: influence of circadian cycle Int J Obes Relat Metab Disord 22 1998 728 733
122. P.Z. Zimmet, V.R. Collins, M.P. de Courten, A.M. Hodge, G.R. Collier, and G.K. Dowse Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius. Mauritius NCD Study Group Int J Obes Relat Metab Disord 22 1998 171 177
123. A. Falorni, V. Bini, D. Molinari, F. Papi, F. Celi, and G. Di Stefano Leptin serum levels in normal weight and obese children and adolescents: relationship with age, sex, pubertal development, body mass index and insulin Int J Obes Relat Metab Disord 21 1997 881 890
124. A. Kennedy, T.W. Gettys, P. Watson, P. Wallace, E. Ganaway, and Q. Pan The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure J Clin Endocrinol Metab 82 1997 1293 1300
125. J.C. Hardwick, G.R. Van Den Brink, G.J. Offerhaus, S.J. Van Deventer, and M.P. Peppelenbosch Leptin is a growth factor for colonic epithelial cells Gastroenterology 121 2001 79 90
126. P. Stattin, R. Palmqvist, S. Soderberg, C. Biessy, B. Ardnor, and G. Hallmans Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden Oncol Rep 10 2003 2015 2021
127. Y. Jiang, J.B. Wilk, I. Borecki, S. Williamson, A.L. DeStefano, and G. Xu Common variants in the 5′ region of the leptin gene are associated with body mass index in men from the National Heart, Lung, and Blood Institute Family Heart Study Am J Hum Genet 75 2004 220 230
128. O. Mammes, D. Betoulle, R. Aubert, B. Herbeth, G. Siest, and F. Fumeron Association of the G-2548A polymorphism in the 5′ region of the LEP gene with overweight Ann Hum Genet 64 2000 391 394
129. J. Hager, K. Clement, S. Francke, C. Dina, J. Raison, and N. Lahlou A polymorphism in the 5′ untranslated region of the human ob gene is associated with low leptin levels Int J Obes Relat Metab Disord 22 1998 200 205
130. A.H. Kissebah, G.E. Sonnenberg, J. Myklebust, M. Goldstein, K. Broman, and R.G. James Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome Proc Natl Acad Sci U S A 97 2000 14478 14483
131. N. Vionnet, H. Hani El, S. Dupont, S. Gallina, S. Francke, and S. Dotte Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24 Am J Hum Genet 67 2000 1470 1480
132. C. Menzaghi, T. Ercolino, R. Di Paola, A.H. Berg, J.H. Warram, and P.E. Scherer A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome Diabetes 51 2002 2306 2312
133. E. Filippi, F. Sentinelli, V. Trischitta, S. Romeo, M. Arca, and F. Leonetti Association of the human adiponectin gene and insulin resistance Eur J Hum Genet 12 2004 199 205
134. J.M. Lehmann, L.B. Moore, T.A. Smith-Oliver, W.O. Wilkison, T.M. Willson, and S.A. Kliewer An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) J Biol Chem 270 1995 12953 12956
135. I. Barroso, M. Gurnell, V.E. Crowley, M. Agostini, J.W. Schwabe, and M.A. Soos Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension Nature 402 1999 880 883
136. S.S. Deeb, L. Fajas, M. Nemoto, J. Pihlajamaki, L. Mykkanen, and J. Kuusisto A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity Nat Genet 20 1998 284 287
137. J.R. Jones, C. Barrick, K.A. Kim, J. Lindner, B. Blondeau, and Y. Fujimoto Deletion of PPAR{gamma} in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance Proc Natl Acad Sci U S A 102 2005 6207 6212
138. S. Landi, V. Moreno, L. Gioia-Patricola, E. Guino, M. Navarro, and J. de Oca Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer Cancer Res 63 2003 3560 3566
139. Z. Gong, D. Xie, Z. Deng, R.M. Bostick, S.J. Muga, and T.G. Hurley The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas Carcinogenesis 26 2005 579 585
140. P.G. Cassell, P.J. Saker, S.J. Huxtable, E. Kousta, A.E. Jackson, and A.T. Hattersley Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin Diabetologia 43 2000 1558 1564
141. O.Y. Kim, E.Y. Cho, H.Y. Park, Y. Jang, and J.H. Lee Additive effect of the mutations in the beta3-adrenoceptor gene and UCP3 gene promoter on body fat distribution and glycemic control after weight reduction in overweight subjects with CAD or metabolic syndrome Int J Obes Relat Metab Disord 28 2004 434 441
142. H. Shen, K. Xiang, and W. Jia Effects of uncoupling protein 3 gene -55 C→T variant on lipid metabolism, body fat, its distribution and non-insulin-dependent diabetes mellitus in Chinese Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19 2002 317 321
143. K. Walder, R.A. Norman, R.L. Hanson, P. Schrauwen, M. Neverova, and C.P. Jenkinson Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima Indians Hum Mol Genet 7 1998 1431 1435
144. S. Otabe, K. Clement, C. Dina, V. Pelloux, B. Guy-Grand, and P. Froguel A genetic variation in the 5′ flanking region of the UCP3 gene is associated with body mass index in humans in interaction with physical activity Diabetologia 43 2000 245 249
145. D.J. Halsall, J. Luan, P. Saker, S. Huxtable, I.S. Farooqi, and J. Keogh Uncoupling protein 3 genetic variants in human obesity: the c-55t promoter polymorphism is negatively correlated with body mass index in a UK Caucasian population Int J Obes Relat Metab Disord 25 2001 472 477
146. H. Matsushita, T. Kurabayashi, M. Tomita, N. Kato, and K. Tanaka Effects of uncoupling protein 1 and beta3-adrenergic receptor gene polymorphisms on body size and serum lipid concentrations in Japanese women Maturitas 45 2003 39 45
147. A.F. Reis, D. Dubois-Laforgue, C. Bellanne-Chantelot, J. Timsit, and G. Velho A polymorphism in the promoter of UCP2 gene modulates lipid levels in patients with type 2 diabetes Mol Genet Metab 82 2004 339 344
148. F. Krempler, H. Esterbauer, R. Weitgasser, C. Ebenbichler, J.R. Patsch, and K. Miller A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans Diabetes 51 2002 3331 3335
149. H. Wang, W.S. Chu, T. Lu, S.J. Hasstedt, P.A. Kern, and S.C. Elbein Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion Am J Physiol Endocrinol Metab 286 2004 E1 E7
150. D. Corella, M. Guillen, O. Portoles, J.V. Sorli, V. Alonso, and J. Folch Gender specific associations of the Trp64Arg mutation in the beta3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: interaction with a common lipoprotein lipase gene variation J Intern Med 250 2001 348 360
151. A. Marti, M.S. Corbalan, M.A. Martinez-Gonzalez, and J.A. Martinez TRP64ARG polymorphism of the beta 3-adrenergic receptor gene and obesity risk: effect modification by a sedentary lifestyle Diabetes Obes Metab 4 2002 428 430
152. K. Hao, S. Peng, H. Xing, Y. Yu, A. Huang, and X. Hong beta(3) Adrenergic receptor polymorphism and obesity-related phenotypes in hypertensive patients Obes Res 12 2004 125 130
153. J. Gagnon, P. Mauriege, S. Roy, D. Sjostrom, Y.C. Chagnon, and F.T. Dionne The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts J Clin Invest 98 1996 2086 2093
154. R.A. Hegele, S.B. Harris, A.J. Hanley, H. Azouz, P.W. Connelly, and B. Zinman Absence of association between genetic variation of the beta 3-adrenergic receptor and metabolic phenotypes in Oji-Cree Diabetes Care 21 1998 851 854
155. O. Ukkola, A. Tremblay, and C. Bouchard Beta-2 adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding Int J Obes Relat Metab Disord 25 2001 1604 1608
156. O. Ukkola, T. Rankinen, S.J. Weisnagel, G. Sun, L. Perusse, and Y.C. Chagnon Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study Metabolism 49 2000 1063 1070
157. M. Carlsson, M. Orho-Melander, J. Hedenbro, and L.C. Groop Common variants in the beta2-(Gln27Glu) and beta3-(Trp64Arg)-adrenoceptor genes are associated with elevated serum NEFA concentrations and type II diabetes Diabetologia 44 2001 629 636